Department of Otorhinolaryngology-Head and Neck Surgery, Eulji University School of Medicine, Daejeon, Republic of Korea.
Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Ewha Womans University, Seoul, Republic of Korea.
J Int Adv Otol. 2020 Dec;16(3):382-386. doi: 10.5152/iao.2020.8748.
This study aimed at evaluating the clinical significance of hematological findings in patients with acute peripheral facial palsy.
For this retrospective case series review, 84 patients who visited our university hospital and were diagnosed with Bell's palsy (BP) or Ramsay Hunt syndrome (RHS) between March 2017 and March 2019 were enrolled. We documented their epidemiological details, final diagnoses, House-Brackmann (HB) palsy grades, and pretreatment and day 7 post-hospitalization complete blood counts. The outcome was considered favorable if the HB grade at weeks 10-16 was I or II. We analyzed the hematological findings in terms of diagnosis and the final treatment outcomes.
A higher pretreatment neutrophil-to-lymphocyte ratio (NLR) and neutrophil count and a lower day-7 lymphocyte count were observed in patients with RHS with unfavorable outcomes. In such patients, moderate positive correlations were observed between the pretreatment white blood cell, neutrophil, and basophil counts; the NLR and basophil-to-lymphocyte ratio; and the initial HB grade. Only the latter was a significant risk factor for a poor treatment outcome. In patients with BP, both the initial HB grade and the pretreatment eosinophil count were included in a regression model predicting prognosis.
Inflammation plays an important role in RHS pathogenesis. Initial RHS severity and the response to corticosteroids may determine the final treatment outcome. However, inflammatory markers do not predict all BP outcomes; BP may be etiologically heterogeneous.
本研究旨在评估急性周围性面瘫患者血液学检查结果的临床意义。
本回顾性病例系列研究纳入了 2017 年 3 月至 2019 年 3 月期间在我院就诊并被诊断为贝尔面瘫(BP)或 Ramsay Hunt 综合征(RHS)的 84 例患者。我们记录了他们的流行病学资料、最终诊断、House-Brackmann(HB)面瘫分级以及治疗前和住院后第 7 天的全血细胞计数。如果第 10-16 周的 HB 分级为 I 或 II,则认为结局良好。我们分析了血液学检查结果与诊断和最终治疗结局的关系。
预后不良的 RHS 患者治疗前的中性粒细胞与淋巴细胞比值(NLR)和中性粒细胞计数较高,而淋巴细胞计数较低。这些患者治疗前白细胞、中性粒细胞和嗜碱性粒细胞计数、NLR 和嗜碱性粒细胞与淋巴细胞比值之间存在中度正相关,且与初始 HB 分级相关。只有后者是治疗结局不良的显著危险因素。BP 患者中,初始 HB 分级和治疗前嗜酸性粒细胞计数均被纳入预测预后的回归模型。
炎症在 RHS 发病机制中起重要作用。初始 RHS 严重程度和对皮质类固醇的反应可能决定最终的治疗结局。然而,炎症标志物并不能预测所有 BP 的结局;BP 可能具有异质性的病因。